홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Pyridine → N-(3-{7-(cyclopentylamino)-3-[2-(cyclopentylamino)-4-pyrimidinyl]pyrazolo[1,5-a]pyridin-2-yl}phenyl)methanesulfonamide

HRID 861133
노트
인쇄 미리보기

반응식

HRID 861133 반응식
[NH2:1][C:2]1[CH:3]=[C:4]([C:8]2[C:22]([C:23]3[CH:28]=[CH:27][N:26]=[C:25]([NH:29][CH:30]4[CH2:34][CH2:33][CH2:32][CH2:31]4)[N:24]=3)=[C:11]3[CH:12]=[CH:13][CH:14]=[C:15]([NH:16][CH:17]4[CH2:21][CH2:20][CH2:19][CH2:18]4)[N:10]3[N:9]=2)[CH:5]=[CH:6][CH:7]=1.N1C=CC=CC=1.[CH3:41][S:42](Cl)(=[O:44])=[O:43].C(OCC)(=O)C>CN(C)C=O.O>[CH:17]1([NH:16][C:15]2[N:10]3[N:9]=[C:8]([C:4]4[CH:3]=[C:2]([NH:1][S:42]([CH3:41])(=[O:44])=[O:43])[CH:7]=[CH:6][CH:5]=4)[C:22]([C:23]4[CH:28]=[CH:27][N:26]=[C:25]([NH:29][CH:30]5[CH2:31][CH2:32][CH2:33][CH2:34]5)[N:24]=4)=[C:11]3[CH:12]=[CH:13][CH:14]=2)[CH2:21][CH2:20][CH2:19][CH2:18]1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 1049PyridineHCID 8857Ethyl AcetateHCID 31297Methanesulfonyl chlorideHCID 10297844HCID 10297844, 화합물

생성물 1

HCID 10302061N-(3-{7-(cyclopentylamino)-3-[2-(cyclopentylamino)-4-pyrimidinyl]pyrazolo[1,5-a]pyridin-2-yl}phenyl)methanesulfonamide수율 96%

시약·촉매·용매 2

HCID 962
Water
용매
HCID 6228Dimethylformamide용매

반응 조건

온도
0 °C

실험 절차

To a suspension of 2-(3-aminophenyl)-N-cyclopentyl-3-[2-(cyclopentylamino)-4-pyrimidinyl]pyrazolo[1,5-a]pyridin-7-amine (150, mg, 0.33 mmol) in N,N-dimethylformamide (5 mL) was added pyridine (40 μL, 0.49 mmol). The reaction mixture was cooled to 0° C. under nitrogen, then methanesulfonyl chloride (28 μL, 0.36 mmol) was added dropwise. After stirring at room temperature for 18 hours, the reaction mixture turned clear. Ethyl acetate and water were added and the phases separated. The organic phase was washed with water and brine, then dried over magnesium sulfate. Filtration and concentration, followed by flash chromatography (95:5 chloroform:methanol) gave N-(3-{7-(cyclopentylamino)-3-[2-(cyclopentylamino)-4-pyrimidinyl]pyrazolo[1,5-a]pyridin-2-yl}phenyl)methanesulfonamide (170 mg, 96%) as a yellow syrup. 1H NMR (CDCl3): δ 7.93 (d, 1H), 7.66 (d, 1H), 7.42 (m, 1H), 7.35–7.25 (m, 5H), 6.25 (m, 1H), 5.99 (m, 2H), 5.62 (broad, 1H), 4.29 (m, 1H), 3.96 (m, 1H), 2.94 (s, 3H), 2.10–1.99 (m, 4H), 1.77–1.49 (m, 12H). MS m/z 532 (M+1).

후처리

  1. customthe phases separated
  2. washThe organic phase was washed with water and brine
  3. dry with materialdried over magnesium sulfate
  4. filtrationFiltration and concentration

출처 및 근거

ORD 기록
ord-f9c259688f8c46d49a2e2ad0a09aea97
출처 데이터셋
uspto-grants-2006_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07153855B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트